NEXGEL Secures $1.8 Million Financing for Potential Acquisition

Nexgel

LANGHORNE, PA — NEXGEL Inc. (NASDAQ: NXGL) announced it has secured $1.797 million in financing related to a potential acquisition targeted for the first quarter of 2026, according to a filing with the Securities and Exchange Commission.

The company said the proposed acquisition remains subject to completion of due diligence by both NEXGEL and the investor, as well as other conditions. If the transaction is not completed, the funds will be returned to the investor.

Chief Executive Officer Adam Levy said the company has identified assets for acquisition and received an up-front investor commitment of $1.797 million, with the possibility of an additional $14.869 million investment tied to the transaction, pending due diligence and other requirements.

READ:  FDA Extends Review of Savara’s Molgramostim Application to November

NEXGEL said it expects to provide additional information regarding the potential acquisition during the first quarter of 2026.

Palladium Capital Group LLC acted as placement agent for the financing.

The transaction is described in a Current Report on Form 8-K filed with the SEC on February 10, 2026.

Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.